TheEdgeResearch
Home / Stocks / WXXWY

WuXi Biologics (Cayman) Inc. (WXXWY)

OTC Healthcare Biotechnology
$10.20 ▼ -8.68%
Market Cap
$20.81B
Sector
Healthcare
Industry
Biotechnology
Beta
0.60
52-Wk Range
7.3-14.8
CEO
Zhisheng Chen
Country
CN
Currency
USD

WuXi Biologics (Cayman) Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Wuxi, JS, CN. The stock last traded at $10.20, down 8.68% on the session, giving a market capitalisation of $20.81B. On trailing twelve-month figures it carries a trailing P/E of 28.82, a net margin of 21.2%. Its beta of 0.60 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
28.82
Price / Sales
6.02
Price / Book
2.97
EV / EBITDA
14.36
Gross margin
47.5%
Operating margin
32.4%
Net margin
21.2%
Return on equity
—
Debt / equity
0.06
Current ratio
3.04
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
13,252
IPO date
2017-12-18
Headquarters
Wuxi, JS, CN
About WuXi Biologics (Cayman) Inc.

Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman) Inc. delivers a comprehensive, integrated suite of services spanning the entire biologics lifecycle, from initial discovery through development to large-scale manufacturing. The company's operations have a global footprint, serving clients across the People's Republic of China, North America, Europe, and other international regions. Its diversified offerings also include specialized consultation in biopharmaceutical technology, international sales contracting, the development and deployment of advanced testing methodologies, and robust marketing and sales support. Furthermore, WuXi Biologics is involved in providing dedicated biologics clinical and manufacturing services, the production and distribution of various medical products, contract development and manufacturing (CDMO) for vaccines and associated businesses, and acting as a supplier of key materials. The firm maintains strategic partnerships with notable entities such as ImmuneOncia Therapeutics, Legochem Biosciences Inc., Worg Pharma, OncoC4, and Exelixis Inc.

Comparable companies

WuXi Biologics (Cayman) Inc. is most often compared with the following Healthcare names:

CRLGNNSFLZAGYWUXAY
More research on WXXWY
WXXWY technical analysis WXXWY TheEdge Score Compare against peers
Open full interactive analysis & DCF →